Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-11001832Phase 2Completed
Phase 2, open-label trial of cisplatin + radiotherapy in Cervical Cancer (CC) (2 arms), sponsored by Xijing Hospital. Primary endpoints: efficacy, disease-free survival and 4 more. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-11001832.